Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Thrombosis Update |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666572725000021 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832583061267546112 |
---|---|
author | Daniella Veloria Benjamin Wang Ran Ran David Ha Robert Diep Calvin Diep |
author_facet | Daniella Veloria Benjamin Wang Ran Ran David Ha Robert Diep Calvin Diep |
author_sort | Daniella Veloria |
collection | DOAJ |
format | Article |
id | doaj-art-f58cca81a00940d188168fe7607c623c |
institution | Kabale University |
issn | 2666-5727 |
language | English |
publishDate | 2025-03-01 |
publisher | Elsevier |
record_format | Article |
series | Thrombosis Update |
spelling | doaj-art-f58cca81a00940d188168fe7607c623c2025-01-29T05:02:13ZengElsevierThrombosis Update2666-57272025-03-0118100199Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolismDaniella Veloria0Benjamin Wang1Ran Ran2David Ha3Robert Diep4Calvin Diep5Department of Pharmacy, Stanford Health Care, Palo Alto, CA, United States; Corresponding author.Department of Pharmacy, Stanford Health Care, Palo Alto, CA, United StatesDepartment of Emergency & Critical Care Medicine, Oregon Health & Science University, Portland, OR, United StatesDivision of Infectious Diseases and Geographic Medicine, Stanford University, United StatesDivision of Hematology, Stanford University, Palo Alto, CA, United StatesDepartment of Pharmacy, Stanford Health Care, Palo Alto, CA, United Stateshttp://www.sciencedirect.com/science/article/pii/S2666572725000021 |
spellingShingle | Daniella Veloria Benjamin Wang Ran Ran David Ha Robert Diep Calvin Diep Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism Thrombosis Update |
title | Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism |
title_full | Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism |
title_fullStr | Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism |
title_full_unstemmed | Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism |
title_short | Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism |
title_sort | reduced versus full apixaban lead in dosing following parenteral treatment of acute venous thromboembolism |
url | http://www.sciencedirect.com/science/article/pii/S2666572725000021 |
work_keys_str_mv | AT daniellaveloria reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism AT benjaminwang reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism AT ranran reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism AT davidha reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism AT robertdiep reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism AT calvindiep reducedversusfullapixabanleadindosingfollowingparenteraltreatmentofacutevenousthromboembolism |